Connect with us
Job cuts span US, India and more, staff cite abrupt emails, uncertainty.
Acquisition to create $12.4 billion pharma giant with global scale and biosimilars push
Says GI is not a logo, will not replace Godrej signature across products.
Q4 revenue up 11.1 Per Cent, hyperlocal orders surge 4x, PAT steady
Central bank cites compliance failures; curbs tighten as wind-up looms
